Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan

201155 citationsJournal Article

Authors

Tocilizumab may be a promising biologic agent in refractory ASD.

Good health and well-being

Published in: Modern Rheumatology

Volume 22, Issue 5, pp. 712-719

Field-Weighted Citation Impact: 3.23